292 related articles for article (PubMed ID: 34503994)
1. 5-Aza-4'-thio-2'-deoxycytidine, a New Orally Bioavailable Nontoxic "Best-in-Class": DNA Methyltransferase 1-Depleting Agent in Clinical Development.
Parker WB; Thottassery JV
J Pharmacol Exp Ther; 2021 Nov; 379(3):211-222. PubMed ID: 34503994
[TBL] [Abstract][Full Text] [Related]
2. Novel DNA methyltransferase-1 (DNMT1) depleting anticancer nucleosides, 4'-thio-2'-deoxycytidine and 5-aza-4'-thio-2'-deoxycytidine.
Thottassery JV; Sambandam V; Allan PW; Maddry JA; Maxuitenko YY; Tiwari K; Hollingshead M; Parker WB
Cancer Chemother Pharmacol; 2014 Aug; 74(2):291-302. PubMed ID: 24908436
[TBL] [Abstract][Full Text] [Related]
3. The development of β-selective glycosylation reactions with benzyl substituted 2-deoxy-1,4-dithio-D-
Wishka DG; Lopez OD; Rudchenko VF; Huang G; Bahde R; Kumar V; Denysenko SM; Zhang L; Zhang M; Teicher BA; Morris J
Nucleosides Nucleotides Nucleic Acids; 2021; 40(1):68-95. PubMed ID: 33063584
[TBL] [Abstract][Full Text] [Related]
4. DNA damage, demethylation and anticancer activity of DNA methyltransferase (DNMT) inhibitors.
Laranjeira ABA; Hollingshead MG; Nguyen D; Kinders RJ; Doroshow JH; Yang SX
Sci Rep; 2023 Apr; 13(1):5964. PubMed ID: 37045940
[TBL] [Abstract][Full Text] [Related]
5. Consequences of combining siRNA-mediated DNA methyltransferase 1 depletion with 5-aza-2'-deoxycytidine in human leukemic KG1 cells.
Vispé S; Deroide A; Davoine E; Desjobert C; Lestienne F; Fournier L; Novosad N; Bréand S; Besse J; Busato F; Tost J; De Vries L; Cussac D; Riond J; Arimondo PB
Oncotarget; 2015 Jun; 6(17):15265-82. PubMed ID: 25948775
[TBL] [Abstract][Full Text] [Related]
6. 5-Aza-deoxycytidine induces selective degradation of DNA methyltransferase 1 by a proteasomal pathway that requires the KEN box, bromo-adjacent homology domain, and nuclear localization signal.
Ghoshal K; Datta J; Majumder S; Bai S; Kutay H; Motiwala T; Jacob ST
Mol Cell Biol; 2005 Jun; 25(11):4727-41. PubMed ID: 15899874
[TBL] [Abstract][Full Text] [Related]
7. 5-aza-2'-deoxycytidine induces alterations in murine spermatogenesis and pregnancy outcome.
Kelly TL; Li E; Trasler JM
J Androl; 2003; 24(6):822-30. PubMed ID: 14581508
[TBL] [Abstract][Full Text] [Related]
8. 5-Aza-dC promotes T-cell acute lymphoblastic leukemia cell invasion via downregulation of DNMT1 and upregulation of MMP-2 and MMP-9.
Lin C; Xie Y; Huang W; Lin D; Lin L
Exp Hematol; 2022 Oct; 114():43-53.e2. PubMed ID: 35908628
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of DNA methylation in L1210 leukemic cells by 5-aza-2'-deoxycytidine as a possible mechanism of chemotherapeutic action.
Wilson VL; Jones PA; Momparler RL
Cancer Res; 1983 Aug; 43(8):3493-6. PubMed ID: 6190553
[TBL] [Abstract][Full Text] [Related]
10. Targeting of 5-aza-2'-deoxycytidine residues by chromatin-associated DNMT1 induces proteasomal degradation of the free enzyme.
Patel K; Dickson J; Din S; Macleod K; Jodrell D; Ramsahoye B
Nucleic Acids Res; 2010 Jul; 38(13):4313-24. PubMed ID: 20348135
[TBL] [Abstract][Full Text] [Related]
11. Effects of 5-aza-2'-deoxycytidine on survival and cell cycle progression of L1210 leukemia cells.
Chabot GG; Momparler RL
Leuk Res; 1986; 10(5):533-7. PubMed ID: 2423812
[TBL] [Abstract][Full Text] [Related]
12. Effect of deoxycytidine on the metabolism and cytotoxicity of 5-aza-2'-deoxycytidine and arabinosyl 5-azacytosine in normal and leukemic human myeloid progenitor cells.
Bhalla K; Cole J; MacLaughlin W; Arlin Z; Baker M; Graham G; Grant S
Leukemia; 1987 Dec; 1(12):814-9. PubMed ID: 2447450
[TBL] [Abstract][Full Text] [Related]
13. 5-aza-2'-deoxycytidine therapy in patients with acute leukemia inhibits DNA methylation.
Momparler RL; Bouchard J; Onetto N; Rivard GE
Leuk Res; 1984; 8(2):181-5. PubMed ID: 6201685
[TBL] [Abstract][Full Text] [Related]
14. F-aza-T-dCyd (NSC801845), a Novel Cytidine Analog, in Comparative Cell Culture and Xenograft Studies with the Clinical Candidates T-dCyd, F-T-dCyd, and Aza-T-dCyd.
Morris J; Wishka DG; Lopez OD; Rudchenko V; Huang G; Hoffman SN; Borgel S; Georgius K; Carter J; Stotler H; Kunkel MW; Collins JM; Hollingshead MG; Teicher BA
Mol Cancer Ther; 2021 Apr; 20(4):625-631. PubMed ID: 33811149
[TBL] [Abstract][Full Text] [Related]
15.
Gilmartin AG; Groy A; Gore ER; Atkins C; Long ER; Montoute MN; Wu Z; Halsey W; McNulty DE; Ennulat D; Rueda L; Pappalardi M; Kruger RG; McCabe MT; Raoof A; Butlin R; Stowell A; Cockerill M; Waddell I; Ogilvie D; Luengo J; Jordan A; Benowitz AB
Haematologica; 2021 Jul; 106(7):1979-1987. PubMed ID: 32586904
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy of L1210 and L1210/ARA-C leukemia with 5-aza-2'-deoxycytidine and 3-deazauridine.
Momparler RL; Momparler LF
Cancer Chemother Pharmacol; 1989; 25(1):51-4. PubMed ID: 2480188
[TBL] [Abstract][Full Text] [Related]
17. Differences in DNA damage produced by incorporation of 5-aza-2'-deoxycytidine or 5,6-dihydro-5-azacytidine into DNA of mammalian cells.
Covey JM; D'Incalci M; Tilchen EJ; Zaharko DS; Kohn KW
Cancer Res; 1986 Nov; 46(11):5511-7. PubMed ID: 2428479
[TBL] [Abstract][Full Text] [Related]
18. 5-Aza-2'-deoxycytidine, a DNA methylation inhibitor, induces cytotoxicity, cell cycle dynamics and alters expression of DNA methyltransferase 1 and 3A in mouse hippocampus-derived neuronal HT22 cells.
Yang J; Tian X; Yang J; Cui J; Jiang S; Shi R; Liu Y; Liu X; Xu W; Xie W; Jia X; Bade R; Zhang T; Zhang M; Gong K; Yan S; Yang Z; Shao G
J Toxicol Environ Health A; 2017; 80(22):1222-1229. PubMed ID: 28880816
[TBL] [Abstract][Full Text] [Related]
19. Comparison of DNMT1 inhibitors by methylome profiling identifies unique signature of 5-aza-2'deoxycytidine.
Mackin SJ; O'Neill KM; Walsh CP
Epigenomics; 2018 Aug; 10(8):1085-1101. PubMed ID: 30070602
[TBL] [Abstract][Full Text] [Related]
20. 5-aza-2'-deoxycytidine-induced genome rearrangements are mediated by DNMT1.
Maslov AY; Lee M; Gundry M; Gravina S; Strogonova N; Tazearslan C; Bendebury A; Suh Y; Vijg J
Oncogene; 2012 Dec; 31(50):5172-9. PubMed ID: 22349820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
